| Furuta, Saori |
Case Western Reserve University
United States |
Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer |
5R01CA248304-05 |
|
|
| Fuschiotti, Patrizia |
University Of Pittsburgh At Pittsburgh
United States |
Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides |
5R21CA280445-02 |
|
Wendy Wang, Ph.D., M.Sc. |
| Garcia, Jose M. |
Seattle Inst For Biomedical/Clinical Res
United States |
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT) |
5R01CA279220-02 |
|
Marjorie Perloff, M.D. |
| Geisler, Stefanie |
Washington University
United States |
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy |
5R37CA267905-04 |
PAR-19-325 (R01 Clinical Trial Optional) |
Asad Umar, D.V.M., Ph.D. |
| Germain, Doris A |
Icahn School Of Medicine At Mount Sinai
United States |
Investigating the efficacy of g-Tocotrienol for the prevention of post-partum breast cancer |
1R01CA301372-01 |
|
Anda Vlad, M.D., Ph.D. |
| Germain, Doris A |
Icahn School Of Medicine At Mount Sinai
United States |
Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. |
5R21CA270702-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marjorie Perloff, M.D. |
| Ghamande, Sharad A. |
Augusta University
United States |
Georgia CaRes |
3UG1CA189851-11S1 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Ghobrial, Irene M. |
Dana-Farber Cancer Inst
United States |
Myeloma multidimensional precancer atlas |
1U01CA294507-01 |
|
Nick Hodges, Ph.D. |
| Ghobrial, Irene M. |
Dana-Farber Cancer Inst
United States |
Molecular prediction of myeloma in African Americans |
5U01CA271492-04 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Ghosh, Jayashri |
Temple Univ Of The Commonwealth
United States |
Development of blood-based methylation biomarkers for CRC risk prediction |
5R01CA281948-03 |
|
Matthew Young, Ph.D. |
